nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assimilating new therapeutic interventions into clinical practice: How does hypertension compare with other therapeutic areas?
|
Carruthers, S.George |
|
1999 |
138 |
3S |
p. S256-S260 5 p. |
artikel |
2 |
Current clinical practice in hypertension: The EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation—Regional and Global) project
|
Swales, John D. |
|
1999 |
138 |
3S |
p. S231-S237 7 p. |
artikel |
3 |
Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials
|
He, Jiang |
|
1999 |
138 |
3S |
p. S211-S219 9 p. |
artikel |
4 |
Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile
|
Kannel, William B. |
|
1999 |
138 |
3S |
p. S205-S210 6 p. |
artikel |
5 |
Influence of arterial pulse and reflected waves on blood pressure and cardiac function
|
London, GĂ©rard M. |
|
1999 |
138 |
3S |
p. S220-S224 5 p. |
artikel |
6 |
Integrated approaches to management of hypertension: Promoting treatment acceptance
|
McInnes, Gordon T. |
|
1999 |
138 |
3S |
p. S252-S255 4 p. |
artikel |
7 |
Introduction
|
Julius, Stevo |
|
1999 |
138 |
3S |
p. S203-S204 2 p. |
artikel |
8 |
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
|
Brooks, David P. |
|
1999 |
138 |
3S |
p. S246-S251 6 p. |
artikel |
9 |
Risk reduction associated with lowering systolic blood pressure: Review of clinical trial data
|
Hall, W.Dallas |
|
1999 |
138 |
3S |
p. S225-S230 6 p. |
artikel |
10 |
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker
|
Shusterman, Neil H. |
|
1999 |
138 |
3S |
p. S238-S245 8 p. |
artikel |